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Summary
. Data are presented from the third combined vascu-
lar and peritoneal dialysis access audit.
. In 2014, 53 centres in England, Wales and Northern
Ireland (out of 62) returned data on ﬁrst access from
4,339 incident haemodialysis (HD) patients and
1,090 incident peritoneal dialysis (PD) patients.
. Of the 5,429 incident patients, 20.1% started dialysis
on PD, 27.8% started with an arteriovenous ﬁstula
(AVF), 1.0% with an arteriovenous graft (AVG),
27.1% on a tunnelled line (TL) and 24.0% on a
non-tunnelled line (NTL).
. Older patients (565 years) were more likely to start
haemodialysis using AVF compared to their
younger counterparts (36.2% vs. 32.8%).
. Thirteen of the nineteen centres (68%) using the
physician led percutaneous insertion technique had
over 20% of their incident patients starting on PD
when compared to only seven out of fourteen centres
(50%) which used single technique (open surgical or
laparoscopic) for their PD catheter insertion.
. Wide variations were apparent between centres for
use of AVF as the ﬁrst haemodialysis access ranging
from 10–54%.
. Eight of the 49 centres were achieving close to the
65% target for AV ﬁstula in their incident patients.
. Length of time known to nephrology services and
likelihood of commencing dialysis using either an
AVF or a PD catheter are strongly associated.
Patients who were known to a nephrologist for
over one year were more likely to start dialysis
with AVF, as compared to those who were referred
between 90–365 days (39.2% vs. 24.6%). Similarly,
patients who were known to a nephrologist between
90 days and one year were more likely to start on PD
when compared to patients who were referred ,90
days prior to dialysis start (26.9% vs. 9.1%). By com-
parison, amongst the late presenters, only 3.5% had
ﬁrst access documented as an AVF and 87.3%
started dialysis on either a tunnelled line or a non-
tunnelled line.
. Initial surgical assessment was a key determinant of
the likelihood of AVF formation. Of the incident
patients known to renal services for longer than
three months and in those assessed by a surgeon at
least three months prior to starting dialysis, 71.4%
started dialysis with an AVF whereas of those who
were not seen by a surgeon only 10.8% did.
. Thirty one of the 38 centres were 2 or 3 standard
deviations below the 85% target for prevalent haemo-
dialysis patients with an AV ﬁstula.
. For centres returning data on one-year peritoneal
dialysis outcomes, the majority of centres (28/32)
maintained 550% of patients on PD at one year,
having censored for transplantation.
. This report demonstrates wide variations in practice
between centres across several domains in the
provision of dialysis access and further work will
be required to understand the underlying reasons.
Fax +41 61 306 12 34
E-Mail karger@karger.com
www.karger.com/nef
# 2016 The UK Renal Registry
Published by S. Karger AG, Basel
1660–8151/16/1325–0253$39.50/0
This article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense).
Usage and distribution for commercial purposes as well as any
distribution of modified material requires written permission.
Anirudh Rao
UK Renal Registry, Southmead Hospital, Southmead Road,
Bristol, BS10 5NB, UK
Email: renalregistry@renalregistry.nhs.uk
Nephron 2016;132(suppl1):253–278
DOI: 10.1159/000444825
Published online: April 19, 2016
Introduction
High quality vascular access is a key modiﬁable risk
factor for patients on dialysis and is an important
measure of good clinical care. The third combined vascu-
lar and peritoneal dialysis access audit in England, Wales
and Northern Ireland represents the ﬁndings from the
2014 data collection period for patients starting dialysis
between 1st January 2014 and 31st December 2014.
The combined access audit provides information on
timely and appropriate access interventions in order to
achieve permanent access based on the recommendations
and quality requirements stated in Renal Association
clinical practice guidelines and vascular access guidelines
for haemodialysis and peritoneal access [1, 2]. The core
principal of these audits has been to highlight the
performance variation of renal centres across England,
Wales and Northern Ireland and explore factors that
may contribute to the provision of excellent quality vas-
cular and peritoneal access.
The term established renal failure used within this
chapter is synonymous with the terms end stage renal
failure and end stage kidney disease, which are in more
widespread international usage. Patients have disliked
the term ‘end stage’, which reﬂects the inevitable outcome
of this disease.
Methods
All adult renal centres in England, Wales and Northern Ireland
were contacted regarding vascular and peritoneal access for all
incident and prevalent dialysis patients (centre level only) in
2014. Data were collected using Microsoft Excel spreadsheets cir-
culated by the UK Renal Registry (UKRR).
The records were also validated against the UKRR database to
conﬁrm that the population collected at each centre for the audit
was the same as, or representative of, the incident population at
that centre as collected via the usual UKRR quarterly return.
Data checks were made by cross-referencing with the UKRR data-
base. Any patients identiﬁed from the UKRR as not incident to
dialysis between 1st January 2014 and 31st December 2014 were
excluded. Patients were categorised as having AKI for the purposes
of this audit and therefore excluded if they did not match to UKRR
data and their access at three months was recorded as recovered
renal function or not recorded. Similarly, where the reported
prevalent numbers from the audit were more than 10% different
to those in the UKRR database, those centres were excluded.
The cross-referencing also enabled ascertainment of information
on mortality within three months of commencing dialysis.
Centres who reported data on peritoneal dialysis (PD) patients
in the 2013 vascular and peritoneal access audit were asked to
complete a one year follow up of their PD patients. Additional
information was requested on the date of PD catheter failure,
the reason for catheter failure, the number of catheters used during
the year, and the modality in use at one year after starting PD.
Table 11.1 lists the summary of audit measures as stated in the
Renal Association clinical practice guidelines, with explanation for
why some of the audit measures were not reported.
Patients starting haemodialysis (HD) were grouped by type of
ﬁrst vascular access: arteriovenous ﬁstula (AVF), arteriovenous
graft (AVG), tunnelled dialysis line (TL), non-tunnelled dialysis
line (NTL). Patients starting PD were categorised by the insertion
technique: laparoscopic, peritoneoscopic, open surgery, percuta-
neous. Access at three months was deﬁned as the type of access
in use at three months after starting dialysis. If a patient was no
longer receiving dialysis at three months then the reason was
recorded instead, for example died or transplanted. Referral time
was deﬁned as the number of days between the date of ﬁrst
being seen by a renal physician and the date of commencing
dialysis. A patient was classiﬁed as presenting late if they had a
referral time of less than 90 days. In the analyses involving whether
or not a patient had received surgical assessment at least three
months before starting dialysis, patients were excluded if they
were categorised as a late presenter.
Access failure was deﬁned as the access no longer being usable
for dialysis. Data about the date and cause of access failure was col-
lected. For the purposes of analysis, access failures were grouped
into ﬁve groups (maturation, mechanical, infection, other and
unknown) for HD failures and six groups (infection, catheter
related, solute/water clearance, leaks/hernia, other and unknown)
for PD failures. Those grouped into ‘other’ included conservative
management, dialysis withdrawn and line replaced. Access failure
was censored for death, transplantation, withdrawal from renal
replacement therapy (RRT) and elective switching of access type.
It was the intention to only capture access failures relating to the
ﬁrst type of access. If the reason recorded for access failure was
not related to the ﬁrst type of access recorded, then the data was
not included in this analysis.
Separate and combined analyses have been performed for
incident HD patients and incident PD patients as appropriate.
Due to the exploratory nature of the audit the analyses have
been limited to descriptive statistics of frequencies, percentages
and unadjusted associations between variables. If a centre had
more than 50% missing returns for a particular data ﬁeld, then
all patients from that centre were excluded from analyses involving
that data ﬁeld. The data were analysed using SAS 9.3.
Results
Inclusion and exclusion criteria
Figure 11.1 is a ﬂow diagram of exclusions. Of the 62
centres contacted, data were received from 54 centres.
In the three years of the running of the combined
audit, three centres have not contributed data (Carshal-
ton, Coventry, Kent) with three centres having contribu-
ted only once (Bristol, Dudley, London Guys). Only one
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centre was excluded due to poor data quality (Ipswich).
Patients (n = 558) who did not match when cross-refer-
encing with the UKRR database and whose access at three
months was ‘recovered renal function’ were categorised
as having AKI for the purposes of this audit and excluded.
Fifteen patients were excluded from all analyses due to
missing RRT start date or ﬁrst access type.
Data completeness
Fifty-three centres returned data on ﬁrst dialysis access
for 4,339 incident HD patients and 1,090 incident PD
patients. The UKRR incident patient data for the same
year were 4,895 HD and 1,396 PD, thus there were access
returns on 88.6% of HD and 78.1% of PD patients. The
patient demographic returns via the access audit corre-
lated well with the data returns made via the usual
UKRR quarterly returns. The completeness of all
variables in the audit was over 80% apart from body
mass index (BMI) which was 54.3% (data not shown).
Variations in ﬁrst dialysis access
Patient demographics
The median patient age when starting RRT was 68
years in the HD cohort and 61 years for patients com-
mencing PD. Overall, 63.7% of the patients were male,
36.3% female; the proportional distribution of the sexes
was similar for both the HD and PD subgroups.
A signiﬁcant proportion of patients starting dialysis
had diabetes (53.6%), however diabetes associated
nephropathy was the primary renal disease (PRD) in
only 26.2% (table 11.2).
Table 11.3 presents HD and PD patient subgroups
stratiﬁed by age, dichotomised body mass index (BMI)
(430 or .30), PRD, referral time (,90 or 590 days)
and surgical assessment status.
There was an association between the access modality
(HD vs. PD), referral time (,90 days vs.590 days) and
surgical assessment status in excess of three months prior
to dialysis start. The following observations can be made:
Table 11.1. Summary of audit measures stated in Renal Association clinical practice guidelines for dialysis access
RA audit measure/guideline Reported Reason for non-inclusion
HD access
1 Proportion of patients whose ﬁrst haemodialysis treatment is with an arteriovenous
ﬁstula:
Yes
1a Stratiﬁed by new patients with established renal failure and known to the
nephrology team for .90 days
Yes
1b Stratiﬁed by new patients with established renal failure and known to the
nephrology team for 490 days
Yes
1c Patients with a failed renal transplant No Not captured by the audit
1d Patients transferred permanently from PD to haemodialysis No Not captured by the audit
2 65% of all patients commencing haemodialysis should commence with an AV ﬁstula Yes
3 A centre should measure the proportion of prevalent long term haemodialysis
patients receiving dialysis via a ﬁstula, an arteriovenous graft and a tunnelled or a
non-tunnelled line
Yes
4 85% of all prevalent patients on haemodialysis should receive dialysis via a
functioning arteriovenous ﬁstula
Yes
5 Complications related to vascular access Yes
5a Rupture of vascular access (ﬁstula and graft) Partly Incident patients only
PD access
1 Catheter patency – more than 80% of catheters should be patent at 1 year
(censoring for death and elective modality change)
Yes
2 Complications following PD catheter insertion: Partly
2a Bowel perforation ,1% No Not captured by the audit
2b Signiﬁcant haemorrhage ,1% No Not captured by the audit
2c Exit site infection within 2 weeks of catheter insertion ,5% No Not captured by the audit
2d Peritonitis within 2 weeks of catheter insertion ,5% Yes
2e Functional catheter problem requiring manipulation or replacement or leading to
technique failure ,20%
No Not captured by the audit
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For HD:
. AVF was the initial access for 34.8% of patients, with
1.2% with an AVG, 34.0% on a tunnelled line and
30.0% on a non-tunnelled line. The percentage of
patients starting with an AVF had been stable for
the previous three years but has since fallen from
40.7% in 2013. The majority of centres are failing
to achieve the target as stated in the Renal Associ-
ation guidelines (65% of all patients commencing
haemodialysis should commence with an AVF).
. Patients aged 65 or over were more likely to start
RRT with an AVF (36.2%) when compared to
patients,65 years (32.8%). Similarly, older patients
were less likely to start on a tunnelled line (30.3% vs.
38.7%).
. BMI had a positive impact on vascular access with
48.9% of the patients with BMI .30 starting on AVF
compared to 36.8% of the patients with BMI430.
. Patients with polycystic kidney disease (PKD) as
primary renal diagnosis were most likely to start
with an AVF (66.1%).
. Patients, who were referred at least 90 days prior to
commencing dialysis, were more likely to start on
AVF compared to those starting more acutely
(48.4% vs. 3.8%).
. A high proportion of patients who were referred at
least 90 days prior to commencing dialysis, start
Total number of incident patients 
in dialysis access audit 6,072
(54 centres)
Total number of patients in 
dialysis access audit data 6,002
(53 centres)
Total number of incident patients 
in dialysis access audit data 5,444 
(53 centres)
70 patients (1 centre) excluded 
due to poor quality data
15 patients excluded as missing 
access at start
Total number of patients in 
analysis 5,429 (53 centres)
558 patients excluded as they did 
not match to UKRR data and their 
access at 3 months was recovered 
renal function
Fig. 11.1. STROBE ﬂow diagram of exclusions
Table 11.2. Patient demographics
Total HD PD
Variable N = 5,429 N = 4,339 N = 1,090
Age Median (IQR) 66 (53, 76) 68 (55, 77) 61 (48, 72)
BMI Median (IQR) 27 (24, 32) 27 (24, 32) 27 (24, 31)
N (%) N (%) N (%)
Gender Female 1,972 (36.3) 1,588 (36.6) 384 (35.2)
Male 3,457 (63.7) 2,751 (63.4) 706 (64.8)
Diabetes Missing 625 (11.5) 528 (12.2) 97 (8.9)
Yes 2,908 (53.6) 2,267 (52.2) 641 (58.8)
No 1,896 (34.9) 1,544 (35.6) 352 (32.3)
PRD Missing 247 (4.5) 202 (4.7) 45 (4.1)
Diabetes 1,423 (26.2) 1,124 (25.9) 299 (27.4)
Glomerulonephritis 624 (11.5) 448 (10.3) 176 (16.1)
Hypertension 324 (6.0) 261 (6.0) 63 (5.8)
Other 1,090 (20.1) 957 (22.1) 133 (12.2)
Polycystic kidney 243 (4.5) 165 (3.8) 78 (7.2)
Pyelonephritis 264 (4.9) 225 (5.2) 39 (3.6)
Renal vascular disease 347 (6.4) 283 (6.5) 64 (5.9)
Uncertain 867 (16.0) 674 (15.5) 193 (17.7)
IQR = interquartile range; BMI = body mass index; PRD = primary renal diagnosis; HD = haemodialysis; PD = peritoneal dialysis
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dialysis on a tunnelled (32.6%) or a non-tunnelled
(17.3%) line.
. Patients who had been seen by a surgeon at least
three months before starting dialysis were more
likely to start with an AVF than those not assessed
(70.2% vs. 5.6%).
For PD:
. For 1,090 ﬁrst PD catheters, the insertion techniques
were 38.1% open surgical, 18.1% laparoscopic, 1.8%
peritoneoscopic and 28.3% percutaneous. Insertion
technique was not reported for the remaining 13.7%.
. There was a greater proportion of patients who
underwent percutaneous PD catheter insertion in
the BMI 430 group in comparison with those
with BMI .30 (22.7% vs. 14.9%).
. Referral time had an inﬂuence on PD catheter inser-
tion technique; 38.6% of patients referred less than
90 days before starting dialysis underwent percuta-
neous insertion compared to 27.0% of patients
known longer to the service. These data were
reversed for general surgical insertion: 26.0% of
patients who presented late versus 39.7% of patients
who did not present late.
. Patients who were assessed by a surgeon at least
three months before starting dialysis were more
likely to undergo open surgical placement (39.3%
vs. 29.6% for non-surgical assessment).
Figure 11.2 shows haemodialysis access stratiﬁed by
PRD. The proportional distribution of PD access was
reasonably similar for different primary renal disease
Table 11.3. Patient characteristics stratiﬁed by type of ﬁrst dialysis access
Variable
HD
N
HD patients
PD
N
PD patients
AVF AVG TL NTL
Open
surgery
Laparo-
scopic
Peritoneo-
scopic
Percuta-
neous Missing
Total patients 4,339 1,508 54 1,474 1,303 1,090 415 197 20 309 149
% 34.8 1.2 34.0 30.0 38.1 18.1 1.8 28.3 13.7
Age at ﬁrst dialysis % %
,65 1,889 32.8 1.2 38.7 27.3 640 38.3 18.1 2.2 28.6 12.8
565 2,450 36.2 1.3 30.3 32.2 450 37.8 18.0 1.3 28.0 14.9
BMI (kg/m2)
430 1,403 36.8 1.9 36.3 25.1 423 43.7 14.9 3.8 22.7 14.9
.30 745 48.9 1.3 29.4 20.4 161 49.1 18.0 1.9 14.9 16.1
No BMI 605 18.5 1.0 29.6 50.9 84 44.0 20.2 1.2 23.8 10.7
PRD
Diabetes 1,124 40.9 1.3 37.5 20.2 299 36.5 18.4 1.7 29.1 14.4
GN 448 34.2 0.4 41.5 23.9 176 39.8 19.9 2.8 27.8 9.7
Hypertension 261 50.6 0.8 28.4 20.3 63 33.3 17.5 1.6 34.9 12.7
No PRD 202 17.8 0.5 33.2 48.5 45 31.1 8.9 0.0 40.0 20.0
Other 957 15.7 0.8 30.8 52.7 133 35.3 21.1 1.5 24.1 18.0
PKD 165 66.1 3.0 26.1 4.8 78 56.4 19.2 1.3 14.1 9.0
Pyelo 225 41.3 2.2 33.3 23.1 39 35.9 20.5 2.6 25.6 15.4
RVD 283 38.2 1.1 31.1 29.7 64 43.8 9.4 3.1 28.1 15.6
Uncertain 674 39.6 1.9 33.2 25.2 193 35.2 18.1 1.6 32.1 13.0
Referral time (days)
,90 1,275 3.8 0.2 37.3 58.7 127 26.0 22.0 1.6 38.6 11.8
590 3,002 48.4 1.7 32.6 17.3 962 39.7 17.6 1.9 27.0 13.8
No ref 62 8.1 1.6 32.3 58.1 1 0.0 0.0 0.0 0.0 100
Assessed by surgeon
Missing 59 25.4 0.0 42.4 32.2 81 66.7 13.6 0.0 18.5 1.2
No 2,290 5.6 0.5 44.8 49.1 439 29.6 14.1 2.5 41.2 12.5
Yes 1,910 70.2 2.0 21.2 6.7 557 39.3 22.3 1.6 20.3 16.5
Patients from centres with more than 50% missing data for a variable are excluded from the table for that variable
AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line; GN = glomerulonephritis; BMI =
body mass index; PRD = primary renal diagnosis; PKD = polycystic kidney disease; Pyelo = pyelonephritis; RVD = renal-vascular disease
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but varied for HD access modality. Of note, patients with
polycystic kidney disease were more likely to start HD
with an AVF (66.1%). Where no primary renal diagnosis
was available, patients were more likely to start dialysis
with a non-tunnelled dialysis venous catheter (48.5%).
Figure 11.3 shows the distribution of haemodialysis
access modality and PD catheter insertion technique stra-
tiﬁed by BMI. As noted in table 11.2, unexpectedly BMI
had a positive impact on type of vascular access with
only 49.8% of the patients with BMI .30 kg/m2 starting
on a catheter compared to 61.4% of the patients with BMI
430 kg/m2. In relation to peritoneal dialysis access,
patients with BMI .30 kg/m2 were more likely to
undergo open surgical placement (58.5%) than those
with BMI 430 kg/m2 (51.4%). The percutaneous
approach was less likely to be used in patients in the
higher BMI category (17.8%) compared to those with a
lower BMI (26.7%). The peritoneoscopic or laparoscopic
approach was used in a similar proportion of patients in
both BMI groups. It should be noted that the analysis was
limited due to a high proportion of missing data for BMI.
Figure 11.4 shows PD catheter insertion technique by
centre. Centres reporting less than ﬁve patients on PD
were not considered for analysis (n = 8). Seven centres
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Fig. 11.4. PD catheter insertion technique stratiﬁed by centre
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reported less than ﬁve patients using PD catheters for ﬁrst
dialysis in 2013. There continues to be a strong tendency
for many centres to rely on one single approach to PD
catheter placement, with 15 centres reporting use of a single
technique for all of their patients mainly open surgical or
laparoscopic. Two centres (Birmingham Heartlands,
Southend) used percutaneous technique close to all of
their PD catheter insertions with a further two centres
(Derby, Wolverhampton) employing this technique in
about 90% of cases. Fifteen other centres reported using
the physician led percutaneous insertion technique. Thir-
teen of the nineteen centres (68.4%) using the physician
led percutaneous insertion technique had over 20% of
their incident patients starting on PD with three centres
(Southend, Derby, Wolverhampton) having close to 40%
of their incident patients starting on PD. By comparison
only seven out of fourteen centres (50.0%) using single
technique (open surgical or laparoscopic) had over 20%
of their incident patients starting on PD (ﬁgure 11.5).
First dialysis access by renal centre
Figure 11.5 shows type of ﬁrst dialysis access by centre.
Approximately a quarter of the patients started with an
AVF (27.8%) with over half of patients starting with a
TL or NTL (51.2%) with approximately a 50–50 split
between the two access types. Variations were apparent
between centres when considering patients commencing
dialysis via an AVF, ranging from ,15% (London West,
Carlisle) to.50% (Doncaster, Clwyd). Some centres had
over 50% of patients starting dialysis on a tunnelled line
(London West, Colchester). The use of arteriovenous
graft as the ﬁrst dialysis access was between 0–11 percent
with only 21 of the 53 centres opting to use this.
Use of a PD catheter as ﬁrst access varied between
.40% (Derby, Southend) and 0% (Clwyd).
The Renal Association (RA) guidelines on vascular
access for haemodialysis recommends 65% of all patients
commencing haemodialysis should commence with an
AV ﬁstula. This is depicted in ﬁgure 11.6 with patients
who presented late excluded for this analysis. Eight of
the 49 centres (Chelmsford, York, Basildon, Derby, Liver-
pool Aintree, Doncaster, Stoke, Shefﬁeld) reporting
incident vascular access data were achieving close to the
RA recommendations (.60%) with one centre achieving
above 2 standard deviations (Stoke). However, there were
12 centres below 2 standard deviations and a further 15
centres below 3 standard deviations. These centres can
be identiﬁed using ﬁgure 11.11. The results have to be
cautiously interpreted due to non-adjustment for any
patient related factors.
First dialysis access and referral time
Figure 11.7 shows a clear association between time
known to a nephrologist and a patient starting haemo-
dialysis with an AVF. A greater proportion of patients
who were known to a nephrologist for over one year
started dialysis with an AVF, as compared to those who
were referred between 90–365 days (39.2% vs. 24.6%).
Similarly, patients who were known to a nephrologist
between 90 days to one year were more likely to start
on PD when compared to patients who were referred
,90 days prior to dialysis start (26.9% vs. 9.1%).
Figure 11.8 shows PD catheter insertion technique by
referral time. Patients who were ﬁrst seen by a nephrolo-
gist ,90 days before starting RRT were more likely to
undergo percutaneous insertion when compared to
patients who were known between 90–365 days and
.365 days (38.6% vs. 32.8% vs. 25.6%). These results
may be due to centre effect and a reﬂection of practice
patterns within the centre. Of the 13 centres that used
the percutaneous insertion technique for over 50% of
their PD catheters, ﬁve (Derby, London Barts, Man-
chester Royal Inﬁrmary, Stoke, Wolverhampton) had
over 20% of their patients presenting late starting on
PD (ﬁgures 11.4 and 11.10). Open surgical technique
was less likely to be used in the patients presenting late
when compared to the patients who were known over
365 days, probably because of having a lesser likelihood
of seeing a surgeon (26.0% vs. 40.2%).
Figure 11.9 shows ﬁrst access for centres providing
data for patients presenting to a nephrologist 590 days
prior to dialysis start. Amongst the 4,027 patients, only
36.2% started with an AVF, below the Renal Association
target and 23.9% started with a PD catheter. Despite
being known to a nephrologist for over three months
38.6% of the patients started on a TL or NTL. As illus-
trated in ﬁgure 11.9 there was a signiﬁcant variation
between centres.
Figure 11.10 shows ﬁrst access for centres providing
data for patients presenting late (known to renal services
for,90 days). Amongst the 1,402 patients for whom data
were reported, 33.9% started dialysis on a tunnelled line,
53.4% on a non-tunnelled line and 9.1% using a PD
catheter with only 3.5% having ﬁrst access documented
as an AVF.
In nine centres, more than 15% of patients presenting
late had a peritoneal dialysis catheter inserted for use as
ﬁrst dialysis access and as a result had a lower require-
ment for tunnelled or non-tunnelled lines. The overall
proportion of patients presenting late starting with an
AVF for all of the centres was 3.5%. Three centres
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Fig. 11.5. Type of ﬁrst dialysis access stratiﬁed by centre
Centres are ordered by the percentage of patients starting dialysis with a PD catheter
PD = peritoneal dialysis; AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line
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however had over 15% of the patients who presented late
starting with an AVF (Shrewsbury 27.5%, Colchester
20.0%, Derby 17.6%). This could be explained by a
multitude of factors ranging from surgical access assess-
ment and formation to ongoing evaluation of an AVF
to enhance maturation and earlier cannulation. The
number of patients presenting late reported in some
centres was extremely small and it is difﬁcult to make
ﬁrm observations about clinical pathways for the
development of dialysis access in this cohort.
Figure 11.11 shows the type of haemodialysis access in
patients known to the renal service for at least 90 days.
There was variation for patients starting haemodialysis
with an AVF, with ﬁve centres (Ulster, Stoke, Doncaster,
York, Chelmsford) achieving 65% or over with London
West and Shrewsbury at the other end at ,20%. The
centres with highest tunnelled line use were London
West (72.7%), Colchester (67.6%) and Carlisle (66.7%)
with over twice the overall proportion of all the centres
combined (32.6%). There were eleven centres who
reported over 30% of patients as starting on non-
tunnelled lines despite being known to the centre for at
least 90 days (Shrewsbury (40.0%), London St Georges
(39.2%), Belfast (48.8%), London Kings (34.9%), Wrex-
ham (33.3%), Wirral (33.3%), Reading (38.8%), Antrim
(37.5%), Manchester Royal (32.7%), Swansea (32.0%),
York (30.4%)). It will be important to understand the
variations in practice patterns that lie behind these
statistics, which were not provided by current data.
First dialysis access and surgical assessment
Figure 11.12 highlights the proportion of patients
referred for surgical assessment at least three months
prior to starting dialysis. There was considerable
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Fig. 11.9. Type of access used for ﬁrst dialysis in patients presenting to a nephrologist 590 days prior to dialysis start
PD = peritoneal dialysis; AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line
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Fig. 11.10. Type of access used for ﬁrst dialysis in patients presenting to a nephrologist ,90 days prior to dialysis start
PD = peritoneal dialysis; AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line
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Fig. 11.11. Type of ﬁrst access for haemodialysis patients stratiﬁed by centre restricted to patients known at590 days prior to dialysis start
AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line
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variation between the renal centres. Overall, the pro-
portion referred to a surgeon was highest in Ulster
(100%), Wrexham (87.2%), Bangor (85.0%), Carlisle
(82.8%) and Doncaster (81.3%). This usually resulted in
a high proportion of patients starting with either an
AVF or PD catheter. Carlisle had only 13.8% starting
with an AVF but had 48.3% starting on PD (refer to
ﬁgure 11.9). Conversely, some centres despite having
low rates of surgical assessment, performed well on
their PD catheter rates (ﬁgure 11.9) as they utilised per-
cutaneous PD catheter insertion technique (ﬁgure 11.4).
For example, three of the centres with lowest surgical
assessment, Derby (36.7%), London Barts (27.9%) and
Southend (11.8%) all achieved high PD rates in their
patients who were known to the centre for over three
months (Derby 49.0%, Southend 64.7%, London Barts
36.5%) as these centres utilised percutaneous PD catheter
insertion technique (Derby 89.7%, Southend 91.7%,
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London Barts 61.5%). The end point of achieving deﬁni-
tive access (AVF or PD catheter), is being used here as a
surrogate of the surgical pathway. However, the variation
seen may not be solely or indeed largely down to the
surgical assessment. Firstly, a detailed understanding of
factors that prevent patients from being assessed for access
in a timely fashion is required. Secondly, the variation may
be due to organisational factors e.g. if physicians insert
Tenckhoff catheters then patients starting on PD may
not be referred to the surgeons and therefore those centres
will show lower rates of surgical assessment for AVF in the
audit.
In the 2014 audit returns, a greater proportion of
patients who received surgical assessment at least three
months prior to commencing dialysis underwent open
surgical insertion (48.8% vs. 34.7%) compared to those
who did not (ﬁgure 11.13). This ﬁgure also provides
evidence that the percutaneous PD catheter insertion
technique is utilised where surgeons have not seen the
patient, since it is surgeon independent.
Figure 11.14 demonstrates a strong relationship
between being assessed by a surgeon at least three months
before starting dialysis and the likelihood of starting with
an AVF. This relationship was much stronger than that
between surgical assessment and method of PD catheter
placement. This suggests that the role of surgical assess-
ment was more important in relation to AVF placement.
Of those assessed by a surgeon at least three months prior
to starting dialysis, 71.4% started dialysis with an AVF
whereas of those who were not seen by a surgeon only
10.8% did.
Dialysis access at three months after starting RRT
The type of access used three months after starting
dialysis gives an important insight into the responsive-
ness of the access formation pathway. Table 11.4
expresses the proportion of patients still dialysing using
a particular form of access as a percentage of the access
they originally started dialysis with. For example, 88.4%
of patients starting dialysis with an AVF were still using
this at three months and 84.3% of patients starting on
PD remained on this modality at three months. Of
patients starting dialysis via a tunnelled line, the majority
continued to use this form of access at three months
(74.8%) and of 1,288 patients who commenced dialysis
via a non-tunnelled line, 697 (54.1%) were dialysing
through a tunnelled line at three months with a signiﬁ-
cant proportion 22.9% (n = 295) dying within three
months. This data suggests that obtaining deﬁnitive
access for HD (AVF/AVG) within three months of start-
ing treatment continues to remain a big challenge.
Figure 11.15 demonstrates the differences in access
outcomes stratiﬁed by centre. By three months, 33.2%
of patients were dialysing using an AVF (range 12.8%
London West to 55.6% Doncaster); 1.3% were using an
AVG (0% many sites to 10.1% Nottingham); 41.2% tun-
nelled lines (8.2% York to 79.2% London West); 1.0%
non-tunnelled lines; 22.1% were using a PD catheter
(0% Leicester to 51.6% Carlisle) and 1.2% transplanted
(0% many sites to 8.1% Leeds).
Access at three months in patients referred to renal
centres ,90 days before starting dialysis was analysed.
Only 45 centres were included in this analysis. The
majority (71.9%) of patients presenting late were being
dialysed using tunnelled lines at three months after
dialysis start (ﬁgure 11.16). The between centre range
was from 21.4% in York to 98.9% at London West.
Amongst patients presenting late, only 9.9% were using
an AVF at three months (individual centres ranged
from 0% in 14 centres to 42.9% in York). PD catheters
were used by 15.5% of patients (range 0% in six centres
to 44.4% in Nottingham). It is interesting to note that
in some centres late presentation was not always associ-
ated with a temporary access such as a TL or a NTL, for
instance in York despite presenting late, 42.9% of their
HD patients were dialysing via AVF at three months.
Table 11.4. Type of dialysis access at three months since dialysis start stratiﬁed by ﬁrst access type
Access in
use at ﬁrst
dialysis (N)
Access in use at three months (%)
AVF AVG TL NTL PD catheter Transplanted Died Stopped/LTFU No data
AVF (1,494) 88.4 0.3 4.8 0.1 0.1 1.1 3.6 1.2 0.3
AVG (54) 3.7 79.6 5.6 0.0 0.0 3.7 5.6 1.9 0.0
TL (1,455) 9.8 0.5 74.8 0.3 3.3 0.8 7.4 2.7 0.3
NTL (1,288) 6.1 0.3 54.1 2.7 5.4 0.2 22.9 7.8 0.5
PD (1,082) 0.7 0.0 6.0 0.4 84.3 2.2 1.6 1.3 3.5
AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line; PD = peritoneal dialysis; LTFU =
lost to follow up
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Fig. 11.15. Type of dialysis access at three months stratiﬁed by centre
AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line; PD = peritoneal dialysis
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Fig. 11.16. Type of dialysis access at three months in patients referred to renal services less than 90 days before starting dialysis, stra-
tiﬁed by centre
Centres reporting on fewer than ﬁve patients were excluded
PD = peritoneal dialysis; AVF = arteriovenous ﬁstula; AVG = arteriovenous graft
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Whilst the reported numbers of patients presenting late
tended to be low in many centres, it will be interesting
to examine the practice pattern that underlies these data.
Figure 11.17 shows access in use at start of dialysis and
at three months after commencing dialysis, displayed for
all patients and also restricted to patients presenting late.
There was a small increase in the proportion of patients
dialysing with an AVF at three months for all patients,
27.8% to 33.7%. In the late presenters, patients dialysing
with an AVF, increased from 3.5% at dialysis start to 9.9%
at three months. Use of a tunnelled line increased at three
months in all patients by 14.6% and in late presenters by
38.1%, which is a reﬂection of conversion from NTL to
TL. PD catheter use saw only a small increase for all
patients (2.3%) and for late presenters (6.5%).
Figure 11.18 shows the percentage access type at
dialysis start from 2012 to 2014 with the analysis
restricted to patients referred at least 90 days prior to
start of dialysis and patients who have not been trans-
planted by three months. The use of an AV ﬁstula as
the incident access dropped by 1.7% between 2012 and
2014 despite the publication of the Renal Association
guidelines in 2011. Reported use of AV graft, tunnelled
line, non-tunnelled line and peritoneal dialysis catheter
has been fairly static over the three-year period.
Prevalent access
Nine centres did not submit prevalent numbers and six
centres were excluded from the analysis as the reported
prevalent access numbers did not match with the number
of prevalent patients at each of the centres in the UKRR
database.
The Renal Association guidelines on vascular access for
haemodialysis recommends 85% of all prevalent patients
on haemodialysis should dialyse using an AV ﬁstula.
Only seven of the 38 centres (Birmingham Heartlands,
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Fig. 11.17. Access in use at start of dialysis
and after three months for those still on
dialysis, displayed for all patients and also
restricted to patients presenting late
PD = peritoneal dialysis; AVF = arteriovenous
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Derby, Stoke, Truro, York, Dorset, Salford) reporting
prevalent data were achieving close to the RA recommen-
dations. Twenty-eight centres were more than three stan-
dard deviations and three centres were more than two
standard deviations below this target (ﬁgure 11.19). The
signiﬁcant variation between centres could be possibly
due to factors in the vascular access pathway (system fac-
tors) which can be modiﬁed. Equally, there has to be
some caution exercised in interpreting these results due
to non-adjustment for any of the measured and unmea-
sured confounders (patient related factors) and warrants
further analysis.
Figure 11.20 shows type of dialysis access in prevalent
patients by centre. Variations were apparent between
centres when considering prevalent patients with an
AV ﬁstula, ranging from less than 20% (London West)
to over 65% in 13 centres. One centre had over 70% of
prevalent patients on a tunnelled or non-tunnelled line
(London West) with two centres (Birmingham Heart-
lands, Derby) at the other end of the spectrum with less
than 10% of patients. The use of an AV graft was between
0% and 10.8% with 35 centres opting to use this.
Use of a PD catheter in prevalent patients varied
between 27.0% (Carlisle, Derby) and 3.7% at Middles-
brough (Colchester does not have any PD patients).
Figure 11.21 shows the percentage of prevalent dialysis
patients with each access type, by year. The percentage of
prevalent patients on PD has shown a decline in trend, in
the three years of the combined access audit with use of
PD declining at 1% every year. The observed fall in
AVF use might be due to a different cohort of centres
having contributed to the prevalent access data. For
example, a large centre such as London West which has
82.2% (1252/1524) of its haemodialysis patients that
dialyse via a catheter could be potentially skewing the
data.
Access failure
Figure 11.22 shows comparative access failure for
the different access types within three months of start.
Access failure was deﬁned as a documented date of
failure/discontinuation recorded within three months of
starting dialysis unless a centre comment indicated that
it was a planned discontinuation. However there were
deﬁciencies in the way that failure was recorded in this
audit. Failure rates were generally higher in the peritoneal
dialysis group with fairly similar failure rates between
open surgical and percutaneous at 10%. Failure rates
were generally around 5% for AVF and AVG demon-
strating its superiority with failure rates for tunnelled
line similar to PD (close to 10%).
The number of HD access failures reported were small.
This may reﬂect poor local documentation procedures
and these data are not included in this report.
Again, numbers of PD access failure were small and
hence drawing any inferences is difﬁcult. However, it
can be seen from ﬁgure 11.23 that peritoneoscopic tech-
nique had one documented failure within three months.
As previously mentioned, percutaneous technique had
fairly comparable failure rates compared to either open
surgical or laparoscopic technique. There was no evi-
dence to suggest differences in failure rates due to leaks
or hernia between the different insertion techniques.
Twelve out of 941 (1.3%) PD patients were reported as
failure of PD due to infection with no obvious difference
in infection rates between the different PD insertion tech-
niques. This was signiﬁcantly lower than the national
target of 5%.
2013 PD access audit one-year follow-up
Centres who reported on PD patients in the 2013 vas-
cular and peritoneal access audits were asked to complete
a one year follow up of their PD patients. The additional
information requested was the date of catheter failure, the
reason for catheter failure, the number of catheters used
during the year, and the modality in use at one year
after starting PD. Of 57 centres who reported data on
PD patients in 2013, 32 completed the one year follow
up, returning data on 753 (73.7%) patients. Plymouth
was excluded from analysis due to over 50% missing
data. The analysis therefore included 719 patients from
31 centres. In these patients, 402 (55.9%) were still on
PD at one year with 87% of these (280/322) still on
their ﬁrst catheter.
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Fig. 11.19. Funnel plot of the percentage of prevalent HD
patients dialysing using an AVF
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Carlis (97)
Derby (334)
Wolve (386)
Stoke (424)
Redng (371)
Wrexm (143)
Hull (399)
L Barts (1,187)
Exeter (509)
Salford (515)
Nottm (443)
York (176)
L Rfree (857)
Bangor  (99)
Dorset (315)
Chelms (164)
Oxford  (541)
Newry (106)
Shrew (215)
Cardff (573)
Donc (212)
B QEH (1,099)
Brightn (505)
Leic  (1,021)
Truro (186)
Ports (723)
Leeds (582)
Sheff (664)
Wirral (233)
Bradfd (238)
B Heart (408)
Belfast (200)
Sund  (248)
Ulster (104)
Stevng  (484)
L West  (1,590)
Middlbr (352)
Colchr (120)
Total (16,823)
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Fig. 11.20. Type of dialysis access in prevalent patients stratiﬁed by centre
Centres are ordered by the percentage of patients starting dialysis with a PD catheter
AVF = arteriovenous ﬁstula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line; PD = peritoneal dialysis
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Fig. 11.21. Percentage of prevalent dialysis
patients with each access type, by year
PD = peritoneal dialysis catheter;
AVF = arteriovenous ﬁstula;
AVG = arteriovenous graft; TL = tunnelled line;
NTL = non-tunnelled line
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Fig. 11.22. Percentage of patients
experiencing failure of ﬁrst access within three
months, by type of ﬁrst access
AVF = arteriovenous ﬁstula; AVG = arteriovenous
graft; TL = tunnelled line; NTL = non-tunnelled
line; PD = peritoneal dialysis catheter
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Fig. 11.23. Reported causes of peritoneal
dialysis access failure within three months
stratiﬁed by catheter insertion technique
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There was a signiﬁcant variation in PD technique sur-
vival with the majority of centres (n = 21) maintaining
550% of patients on PD at one year, however only one
centre maintained 580% on PD at one year (York).
Although in general where it is particularly low,
transplantation seems to be the main beneﬁciary with
variation between centres ranging from 0% to 42.9%.
Having censored for transplantation the proportion of
patients who were on PD was 66.1% with 28 centres
maintaining 550% of patients on PD at one year.
Modality change to haemodialysis varied from 0%
(Middleborough, Swansea) to .25% (Birmingham
Heartlands, Shefﬁeld, Doncaster, Dorset, Sunderland,
Leeds) (ﬁgure 11.24).
Causes of PD access failure within one year of starting
on PD were analysed. There was no evidence to suggest a
difference in the PD failure rates when analysed by percu-
taneous and all of the three other techniques combined.
The reported numbers were too low to draw ﬁrm con-
clusions (n = 152). Unsurprisingly the principal causes
of catheter failure were mechanical or infection related
(ﬁgure 11.25).
Figure 11.26. is a funnel plot which graphically dis-
plays the unadjusted percentage of PD patients experien-
cing a catheter failure within one year of commencement
of RRT across multiple renal centres. PD catheter failure
was censored for transplantation, elective transfer to HD
or death. The results have to be cautiously interpreted
due to the extent of and variation in missing data,
small numbers of patients in some centres and non-
adjustment for any patient related factors.
Of the centres for which data were available (n = 27),
no outlier centres were identiﬁed with failure rates above
the upper 95% ‘alert’ or 99.9% ‘alarm’ limits for PD
catheter failures. Two renal centres reported one-year
catheter failure rate below the 99% control limit (Truro,
Bradford). The mean one-year catheter failure rate was
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Fig. 11.24. Modality at one year after commencing PD, by centre
PD = peritoneal dialysis catheter; Tx= transtplated; HD= haemodialysis
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Fig. 11.25. Causes of PD access failure
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20.2% which all but met the rate recommended in the
guidelines issued by the RA (20%).
Conclusions
This third multisite dialysis access audit from England,
Wales and Northern Ireland has provided important
information regarding the variation in access provision
and failure. Data collection is still not optimal, as missing
data across a range of ﬁelds exist.
Haemodialysis catheter (TL, NTL) use continued to
remain high in incident and prevalent haemodialysis
patients. In incident dialysis patients, tunnelled lines
were used in approximately 41% of patients three
months’ post dialysis start and this ﬁgure was higher
for patients presenting late. Particularly in the late pre-
senters, this report highlights an opportunity for use of
percutaneous PD access technique in order to increase
the uptake of PD and reduce catheter use.
This audit has shown that age had a bigger impact on
the type of vascular access but not on PD access with
older patients more likely to start dialysis with an AVF
and less likely using a tunnelled line. This data is contrary
to what has been published in the literature with the
HEMO study showing a lower likelihood of having a
ﬁstula in the elderly (37.5% in ,65 years vs. 27.8% in
.65 years; OR 0.64, 95% CI, 0.52 to 0.79) [3]. The distri-
bution of patients starting RRT in the 2014 incident
cohort was 46.6% vs. 53.4% in the under 65’s and over
65’s respectively when compared to 64.7% vs. 35.3% in
the HEMO study. Hence the above observation in the
audit could be down to elderly patients more likely to
start RRT on haemodialysis via an AVF when compared
to the younger patients who have a higher likelihood of
starting with a transplant and may use haemodialysis
via a catheter as a bridge to transplantation. Patients
with polycystic kidney disease were more likely to start
HD with an AVF and demonstrate the effect of PKD as
a marker for planned care, as these patients are often
known to renal services for many years before dialysis
is required.
An interesting ﬁnding from the vascular access audit
over the last couple of years has been the relationship
between BMI and AVF rates. The 2013 and 2014 audits
have shown that there were a higher proportion of
patients starting haemodialysis on an AVF in the BMI
.30 category when compared to the BMI 430 group
with a difference of 12% between the two groups (audit
2013: 54.9% vs. 42.6%; audit 2014: 48.9% vs. 36.8%) [4].
There has been conﬂicting evidence in the literature,
with the HEMO study showing a lower likelihood of
having a ﬁstula (adjusted odds ratio 0.76, 95% CI, 0.65
to 0.87) [3]. On the other hand, recent studies have
shown that obesity may not be associated with increased
failure rates except at the highest BMI quartile and with
the use of peri-operative vein mapping similar success
may be achieved in the higher BMI group [5, 6].
Several guideline statements such as the US Fistula
First Breakthrough Initiative, NKF-KDOQI (National
Kidney Foundation Kidney Disease Outcomes Quality
Initiative), and European Renal Best Practice (ERBP)
Guidelines) strongly promote the use of arteriovenous
ﬁstulae (AVF) and discourage the use of catheters
(CVC); with UK Renal Association recommendations
for a centre to achieve AVF in .65% of the incident
patients and over 85% in prevalent patients [1, 7–9]. A
few centres have demonstrated that these targets are
indeed achievable; the majority of these centres have
implemented local quality improvement projects directed
at the vascular access pathway. The differences in AVF
use in both incident and prevalent patients may be due
to variation in local processes for access planning and
delivery which needs further investigation.
This audit has highlighted that there has been a fall in
the AVF rates both in incident and prevalent patients.
There is also a signiﬁcant disparity between the data
from this audit and the DOPPS data with regards to
prevalent haemodialysis access, with audit data showing
AVF 65.4%, AVG 4.1% and catheter 30.5% respectively
when compared to the DOPPS 4 data for the UK showing
AVF 75%, AVG 6.6% and catheter 18.5% [10–12]. The
vascular access tariff returns have also suggested a
AVF/AVG rate of approximately 75%. The reason for
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Fig. 11.26. Funnel plot of the percentage of PD catheter failures
within one year of insertion
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this disparity is likely to be due to sampling errors. Firstly,
DOPPS only samples 20 UK centres and secondly, due to
a slightly different group of centres contributing to the
data in this year’s and in previous years’ data UKRR
returns.
The latest Renal Association vascular access guidelines
published in May 2015 reduced the targets to 60% of all
incident patients commencing planned haemodialysis
via AVF/AVG and 80% of all prevalent dialysis patients
should dialyse via deﬁnitive access AVF/AVG/PD [13].
The reduction in targets were intended to encourage
more centres to dialyse their patients using deﬁnitive
access rather than to make it easier for the centres to
achieve the new targets. These targets have not been
used in the funnel plots since they were published in
the period not covered by the report. Despite the revised
targets most renal centres continued to fall signiﬁcantly
below the recommendations. There needs to be a con-
solidated effort from all specialties that are involved
with provision of vascular access if the vascular access
standards are to be achieved.
This audit has shown that in many centres percuta-
neous insertion of PD catheters is not used at all or is
underutilised with 42% of the centres using this tech-
nique. However, in those centres using the physician
led percutaneous insertion technique, 68% of them had
over a ﬁfth of their incident patients starting on PD.
The audit data has also shown that patients who were
ﬁrst seen by a nephrologist ,90 days before starting
RRT, were more likely to undergo percutaneous insertion
when compared to patients who were known between
90–365 days and .365 days. Therefore, some centres
that are unable to place PD access in their unplanned
starts probably resort to TL use, clearly this pathway is
unresponsive and presents an ideal opportunity for a
percutaneous initiative in order to increase PD uptake.
Centres with a successful percutaneous PD pathway
(Derby, Stoke, Southend, Wolverhampton), were able to
achieve less than 40% catheter use (TL/NTL) in their
incident patients when compared to a national average
of 51%. Therefore, in centres with low PD penetrance a
successful percutaneous pathway at those centres might
have a big impact on PD uptake and reduce TL use.
Another important point noted in this audit is that
many centres rely only on one technique, usually a
general surgical approach, which may limit responsive-
ness to PD. Several studies have demonstrated equivalent
outcomes between percutaneous and surgical insertion
[14–16]. Hence, the use of the percutaneous technique
pathway whilst being safe, might have a better impact
on achieving responsive PD access service. The work of
Castledine et al has shown that in the UK, PD access
use is multifactorial and depends not only on the ease
of PD catheter placement but also individual patient
characteristics and is also associated with modiﬁable
centre factors [17]. Therefore, improving the ease of PD
catheter placement via implementation of percutaneous
insertion technique in more centres might help to get
over the ﬁrst hurdle towards improving the uptake of PD.
The audit has shown that without surgical assessment,
patients are more likely to require temporary haemo-
dialysis access such as a tunnelled or non-tunnelled
dialysis catheter. Timely surgical assessment is a key
component of the clinical pathway to ﬁstula placement
which usually leads to a successful procedure followed
by successful cannulation. The other improvements
identiﬁed by the DOPPS practice patterns were better
prevalent AVF rates, better skilled surgeons, quicker
referral to operation time and earlier cannulation [12,
18]. The relationship between surgical assessment and
AVF formation was very different from that of PD
catheter placement. It is quite possible that the time
required to plan PD catheter placement is shorter because
there are fewer steps on the PD pathway compared to that
required for AVF formation. For instance, the need for
vein mapping may inﬂuence the timing of AVF place-
ment. Many of the centres that are not able to arrange
timely surgical review resort to TL, this presents an
opportunity to recommend percutaneous PD access to
avoid complications related to the use of haemodialysis
catheters.
This audit has also shown that both AVF and the PD
catheter offer similar sustainability in terms of access at
three months. Percutaneous PD catheter technique had
similar failure rates to the other techniques combined
and hence is a recommendable technique that should
be better exploited.
Several DOPPS studies looked into understanding the
variation in provision of vascular access. In these studies,
time to surgery, cannulation and willingness to take on
more difﬁcult cases came out as very powerful factors
[12, 19]. Similarly, the UKRR needs to ﬁrstly consider, a
survey of the practice patterns and stafﬁng for provision
of vascular and PD access, in all the renal centres to
explore the reason behind the wide variation in haemo-
dialysis access provision between centres which could
lead to potential improvements in access service pro-
vision. Secondly, using statistical techniques such as
Instrument Variable (IV) analysis to explore variations
in centre level survival stratiﬁed by AVF rates at the
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centres with adjustments made for the captured practice
patterns at the centre along with comorbidity, ethnicity,
and deprivation. This approach is the subject of the UK
PD Catheter Study (UKCRN ID 17940) [20].
Similarly, it would be valuable to undertake a case
study exploring the role of percutaneous PD catheter
insertion for primary access comparing high performing
with low performing centres to understand differences in
pathways of care. This presents a quality improvement
opportunity in line with recommendations from CG125
(NICE technology appraisal) with the potential to
increase PD uptake and reduce TL use with beneﬁcial
effects on MSSA bacteraemia rates and cost.
In summary, 100 percent coverage and better data
returns in the subsequent audits from all renal centres
is needed. There were still signiﬁcant variations between
centres in provision of dialysis access in patients with
established renal failure. Further work is needed to
explore the reasons behind these variations in order to
deﬁne the best practice.
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